RUTH BIBEAU: Open Payments
NPI 1851983704 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$335 in 11 payments from 7 companies in 2025. Trend: 2023 $174 · 2024 $155 · 2025 $335
Food & beverage: $335
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $113 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $101 |
| Janssen Pharmaceuticals, Inc | 2 | $39 |
| E.R. Squibb & Sons, L.L.C. | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
Products named: Auvelity, CAPLYTA, SPRAVATO, COBENFY, REXULTI, FANAPT, Jornay PM.
Industry payments across MS — which companies pay providers there.
